Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Ecology and Evolution
|
December 15, 2015
Testing projected wild bee distributions in agricultural habitats: predictive power depends on species traits and habitat type
Leon Marshall, Luísa G Carvalheiro, Jesús Aguirre-Gutiérrez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 30, 2016
Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy
Lucy Lim, Alexander Thompson, Scott Patterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 22, 2022
Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using <sup>18</sup>F-FDG PET
Martin H Cherk, Robert Khor, Thomas W Barber, et al.
BMC Public Health
|
May 31, 2018
Longitudinal study of health, disease and access to care in rural Victoria: the Crossroads-II study: methods
Kristen M Glenister, Lisa Bourke, Leslie Bolitho, et al.
Plos Pathogens
|
December 31, 2009
Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection
Shuo Li, Stefan Floess, Alf Hamann, et al.
Plos One
|
August 21, 2012
Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individuals
Shuo Li, Stuart Roberts, Magdalena Plebanski, et al.
Antiviral Therapy
|
March 31, 2011
Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients
Cristina Baleriola, William D Rawlinson, Gregory J Dore, et al.
Alimentary Pharmacology & Therapeutics
|
March 3, 2025
Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective
Natassia Tan, Christopher Zampogna, Kate Lynch, et al.
Journal of Hepatology
|
November 28, 2012
Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure
Graham R Foster, Stefan Zeuzem, Pietro Andreone, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 17, 2014
Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study
Thomas Berg, Pietro Andreone, Stanislas Pol, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Ecology and Evolution
|
December 15, 2015
Testing projected wild bee distributions in agricultural habitats: predictive power depends on species traits and habitat type
Leon Marshall, Luísa G Carvalheiro, Jesús Aguirre-Gutiérrez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 30, 2016
Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy
Lucy Lim, Alexander Thompson, Scott Patterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 22, 2022
Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using <sup>18</sup>F-FDG PET
Martin H Cherk, Robert Khor, Thomas W Barber, et al.
BMC Public Health
|
May 31, 2018
Longitudinal study of health, disease and access to care in rural Victoria: the Crossroads-II study: methods
Kristen M Glenister, Lisa Bourke, Leslie Bolitho, et al.
Plos Pathogens
|
December 31, 2009
Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection
Shuo Li, Stefan Floess, Alf Hamann, et al.
Plos One
|
August 21, 2012
Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individuals
Shuo Li, Stuart Roberts, Magdalena Plebanski, et al.
Antiviral Therapy
|
March 31, 2011
Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients
Cristina Baleriola, William D Rawlinson, Gregory J Dore, et al.
Alimentary Pharmacology & Therapeutics
|
March 3, 2025
Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective
Natassia Tan, Christopher Zampogna, Kate Lynch, et al.
Journal of Hepatology
|
November 28, 2012
Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure
Graham R Foster, Stefan Zeuzem, Pietro Andreone, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 17, 2014
Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study
Thomas Berg, Pietro Andreone, Stanislas Pol, et al.
Page
of 7